Display options
Share it on

Food Nutr Res. 2016 Apr 07;60:30864. doi: 10.3402/fnr.v60.30864. eCollection 2016.

Therapeutic efficacy of ethanolic extract of Aerva javanica aerial parts in the amelioration of CCl4-induced hepatotoxicity and oxidative damage in rats.

Food & nutrition research

Ahmed H Arbab, Mohammad K Parvez, Mohammed S Al-Dosari, Adnan J Al-Rehaily, Khalid E Ibrahim, Perwez Alam, Mansour S Alsaid, Syed Rafatullah

Affiliations

  1. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  2. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; [email protected].
  3. Department of Pathology, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
  4. Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

PMID: 27059702 PMCID: PMC4826463 DOI: 10.3402/fnr.v60.30864

Abstract

BACKGROUND: Liver diseases, the fifth most common cause of global death, can be metabolic, toxin-induced, or infective. Though approximately 35 Saudi medicinal plants are traditionally used to treat liver disorders, the hepatoprotective potential of Aerva javanica has not been explored.

OBJECTIVE: To investigate the antioxidative and hepatoprotective effect of Aerva javanica.

DESIGN: Total ethanol extract of A. javanica aerial parts was prepared and tested on DCFH-toxicated HepG2 cells ex vivo, and in CCl4-injured Wistar rats in vivo. MTT assay was used to determine cell viability and the serum biochemical markers of liver injury as well as histopathology was performed. In vitro 1,1-diphenyl-2-picrylhydrazyl and β-carotene free-radical scavenging assay and phytochemical screening of the extract were done. Furthermore, A. javanica total extract was standardized and validated by high-performance thin layer chromatographic method.

RESULTS: MTT assay showed that, while DCFH-injured cells were recovered to ~56.7% by 100 µg/ml of the extract, a 200 µg/ml dose resulted in hepatocytes recovery by ~90.2%. Oral administration of the extract (100 and 200 mg/kg.bw/day) significantly normalized the serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase, gamma-glutamyl transferase, alkaline phosphatase, bilirubin, cholesterol, high-density lipoprotein, low-density lipoprotein, very-low-density lipoprotein, triglyceride, and malondialdehyde levels, including tissue nonprotein sulfhydryl and total protein in CCl4-injured rats. In addition, the histopathology of dissected liver also revealed that A. javanica cured the tissue lesion compared to silymarin treatment. In vitro assays revealed strong free-radical scavenging ability of the extract and presence of alkaloids, flavonoids, tannins, sterols, and saponins where rutin, a well-known antioxidant flavonoid, was identified.

CONCLUSIONS: Our findings demonstrate the potential of A. javanica in the attenuation of ex vivo and in vivo hepatotoxicity and oxidative damage. This further suggests its therapeutic value in various liver diseases. However, isolations of the active principles, their mechanisms of action, and other therapeutic contributions remain to be addressed.

Keywords: Aerva javanica; CCl4; DCFH; hepatoprotection; liver diseases; oxidative stress; rutin

References

  1. J Clin Med Res. 2009 Aug;1(3):150-7 - PubMed
  2. Biomed Environ Sci. 2013 Mar;26(3):209-21 - PubMed
  3. Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S44-8 - PubMed
  4. Saudi Pharm J. 2013 Apr;21(2):143-52 - PubMed
  5. Food Chem Toxicol. 2012 May;50(5):1568-75 - PubMed
  6. Biol Pharm Bull. 2005 Jan;28(1):19-23 - PubMed
  7. Pak J Pharm Sci. 2015 Nov;28(6 Suppl):2213-20 - PubMed
  8. Cell Biochem Funct. 2005 May-Jun;23 (3):169-74 - PubMed
  9. J Food Sci. 2012 Jul;77(7):T124-30 - PubMed
  10. Pak J Pharm Sci. 2012 Jul;25(3):565-9 - PubMed
  11. Biomedicine. 1973 Jan 20;19(1):16-9 - PubMed
  12. Anal Biochem. 1968 Oct 24;25(1):192-205 - PubMed
  13. J Sci Food Agric. 2012 May;92 (7):1441-7 - PubMed
  14. Fitoterapia. 2001 Mar;72(3):272-7 - PubMed
  15. Clin Chem. 1980 Dec;26(13):1775-9 - PubMed
  16. World J Gastroenterol. 2014 Oct 28;20(40):14672-85 - PubMed
  17. Steroids. 2013 Nov;78(11):1098-102 - PubMed
  18. Free Radic Biol Med. 1999 Oct;27(7-8):873-81 - PubMed
  19. Arch Pharm Res. 2011 May;34(5):767-74 - PubMed
  20. Fortschr Med. 1982 May 13;100(18):842-5 - PubMed
  21. Chem Cent J. 2012 Jul 31;6(1):76 - PubMed
  22. J Asian Nat Prod Res. 2013 Jul;15(7):708-16 - PubMed
  23. J Hepatol. 1991 Nov;13(3):372-4 - PubMed
  24. Clin Chem. 1973 Mar;19(3):338-40 - PubMed
  25. Acta Pol Pharm. 2012 Mar-Apr;69(2):171-7 - PubMed
  26. J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):31-9 - PubMed
  27. Life Sci. 2006 Jan 11;78(7):713-8 - PubMed
  28. Molecules. 2013 Oct 17;18(10 ):12937-50 - PubMed
  29. N Engl J Med. 2006 Feb 16;354(7):731-9 - PubMed
  30. Indian J Pharm Sci. 2008 Mar-Apr;70(2):265-8 - PubMed
  31. Acta Pharmacol Sin. 2012 Oct;33(10 ):1260-70 - PubMed
  32. Biochimie. 1997 Nov;79(11):629-36 - PubMed
  33. J Endocrinol Invest. 2014 Sep;37(9):783-8 - PubMed
  34. J Ethnopharmacol. 2015 Jun 20;168:66-78 - PubMed
  35. BMC Pharmacol. 2005 Jan 31;5:2 - PubMed
  36. Pak J Pharm Sci. 2013 Jul;26(4):757-60 - PubMed
  37. J Food Sci Technol. 2011 Aug;48(4):412-22 - PubMed
  38. Am J Clin Pathol. 1957 Jul;28(1):56-63 - PubMed
  39. Fundam Clin Pharmacol. 2009 Apr;23 (2):179-88 - PubMed
  40. J Natl Cancer Inst. 1972 May;48(5):1393-401 - PubMed
  41. Fitoterapia. 2002 Dec;73(7-8):557-63 - PubMed
  42. Immunopharmacol Immunotoxicol. 2012 Feb;34(1):157-62 - PubMed

Publication Types